A clinical double-blind trial of topical haloprogin and miconazole against superficial fungal infections.
D000328:Adult; D000368:Aged; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy*; D004311:Double-Blind Method; D004894:Erythrasma / Q000188:drug therapy; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008825:Miconazole / Q000627:therapeutic use*; D008875:Middle Aged; D009824:Ointments; D010647:Phenyl Ethers / Q000627:therapeutic use*; D010915:Pityriasis / Q000188:drug therapy; D011897:Random Allocation; D012874:Skin Diseases, Infectious / Q000188:drug therapy
D007093:Imidazoles; D009824:Ointments; D010647:Phenyl Ethers; D008825:Miconazole